Correction to: Bone Marrow Transplantation https://doi.org/10.1038/s41409-022-01693-8, published online 30 April 2022
The caption of Fig. 1 was corrected from “Transplant outcomes. Non-relapse mortality (a, NRM), relapse incidence (b, RI), leukemia-free survival (c, LFS), and overall survival(d, OS) patients receiving post-transplant cyclophosphamide (PTCy) versus Cyclosporine A (CSA) / methotrexate (MTX)” to “Transplant outcomes. Non-relapse mortality (a, NRM), relapse incidence (b, RI), leukemia-free survival (c, LFS), and overall survival (d, OS) of patients receiving reduced intensity versus myeloablative conditioning regimen”. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nagler, A., Peczynski, C., Dholaria, B. et al. Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia. Bone Marrow Transplant 57, 1854 (2022). https://doi.org/10.1038/s41409-022-01834-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-022-01834-z
